Clinical Trials Browser

Phase NA × Breast Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00503841 2019-04-30

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Phase NA Terminated

44 enrolled 3 charts

Breast Neoplasms